While wild-type HOXA9 is overexpressed in a subset of human AML [58], [59], [60], [61], its effects on primary human hematopoietic cell differentiation and proliferation have not been previously reported, and its contribution to human myeloid leukemogenesis is not clear. This evidence concerns the gene HOXA9 and acute myeloid leukemia.